Genotypes and haplotypes of ABCB1 contribute to TAC chemotherapy response in Malaysian triple negative breast cancer patients

Meta Gene - Tập 16 - Trang 21-27 - 2018
Ahmad Aizat Abdul Aziz1, Md Salzihan Md Salleh2, Ibtisam Mohamad3, Venkata Murali Krishna Bhavaraju4, Maya Mazuwin Yahya5, Andee Dzulkarnaen Zakaria5, Siew Hua Gan6, Ravindran Ankathil1
1Human Genome Centre, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, 16150 Kubang Kerian, Kelantan, Malaysia
2Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, 16150, Kubang Kerian, Kelantan, Malaysia
3Department of Pathology, Hospital Raja Perempuan Zainab II, Kota Bharu, Kelantan, Malaysia
4Adventist Oncology Center, Penang Adventist Hospital, Pulau Pinang, Malaysia
5Department of Surgery, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, 16150, Kubang Kerian, Kelantan, Malaysia
6Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, 47500 Bandar Sunway, Selangor, Malaysia

Tài liệu tham khảo

An, 2017, Regulation of multidrug resistance by microRNAs in anti-cancer therapy, Acta Pharm. Sin. B, 7, 38, 10.1016/j.apsb.2016.09.002

Andersen, 2013, Low ABCB1 gene expression is an early event in colorectal carcinogenesis, PLoS One, 8, 10.1371/journal.pone.0072119

Ankathil, 2017, ABCB1 genetic variants in leukemias: current insights into treatment outcomes, Curr. Pharmacogenomics Pers. Med., 10, 169, 10.2147/PGPM.S105208

Barrett, 2005, Haploview: analysis and visualization of LD and haplotype maps, Bioinformatics, 21, 263, 10.1093/bioinformatics/bth457

Boyle, 2012, Triple-negative breast cancer: epidemiological considerations and recommendations, Ann. Oncol., 23, vi7, 10.1093/annonc/mds187

Brady-West, 2011, Triple negative breast cancer: therapeutic and prognostic implications, Asian Pac. J. Cancer Prev., 12, 2139

Burger, 2003, RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response, Clin. Cancer Res., 9, 827

Cascorbi, 2006, Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs, Pharmacol. Ther., 112, 457, 10.1016/j.pharmthera.2006.04.009

Cetin, 2014, Triple negative breast cancer, Asian Pac. J. Cancer Prev., 15, 2427, 10.7314/APJCP.2014.15.6.2427

Chaturvedi, 2013, Influence of ABCB1 genetic variants in breast cancer treatment outcomes, Cancer Epidemiol., 37, 754, 10.1016/j.canep.2013.04.012

Chen, 2012, Lack of association between MDR1 C3435T polymorphism and chemotherapy response in advanced breast cancer patients: evidence from current studies, Mol. Biol. Rep., 39, 5161, 10.1007/s11033-011-1312-2

Delou, 2017, Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosis, Breast Cancer, 9, 415

Demidenko, 2015, Frequent down-regulation of ABC transporter genes in prostate cancer, BMC Cancer, 15, 10.1186/s12885-015-1689-8

Dent, 2007, Triple-negative breast cancer: clinical features and patterns of recurrence, Clin. Cancer Res., 13, 4429, 10.1158/1078-0432.CCR-06-3045

Fromm, 2002, The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans, Adv. Drug Deliv. Rev., 54, 1295, 10.1016/S0169-409X(02)00064-9

Fung, 2009, A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function, Biochim. Biophys. Acta, 1794, 860, 10.1016/j.bbapap.2009.02.014

George, 2009, A single-nucleotide polymorphism in the MDR1 gene as a predictor of response to neoadjuvant chemotherapy in breast cancer, Clin. Breast Cancer, 9, 161, 10.3816/CBC.2009.n.026

Gottesman, 2002, Multidrug resistance in cancer: role of ATP-dependent transporters, Nat. Rev. Cancer, 2, 48, 10.1038/nrc706

Jelen, 2015, The influence of C3435T polymorphism of the ABCB1 gene on genetic susceptibility to depression and treatment response in polish population - preliminary report, Int. J. Med. Sci., 12, 974, 10.7150/ijms.13119

Ji, 2012, Polymorphisms in genes involved in drug detoxification and clinical outcomes of anthracycline-based neoadjuvant chemotherapy in Chinese Han breast cancer patients, Cancer Biol. Ther., 13, 264, 10.4161/cbt.18920

Jiang, 2008, Correlation between MDR1 methylation status in the promoter region and MDR1 genetic polymorphism in 194 healthy Chinese Han subjects, Pharmacogenomics, 9, 1801, 10.2217/14622416.9.12.1801

Johnstone, 2000, Multiple physiological functions for multidrug transporter P-glycoprotein?, Trends Biochem. Sci., 25, 1, 10.1016/S0968-0004(99)01493-0

Johnstone, 2000, A role for P-glycoprotein in regulating cell death, Leuk. Lymphoma, 38, 1, 10.3109/10428190009060314

Kerb, 2006, Implications of genetic polymorphisms in drug transporters for pharmacotherapy, Cancer Lett., 234, 4, 10.1016/j.canlet.2005.06.051

Kim, 2015, ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy, Cancer Sci., 106, 86, 10.1111/cas.12560

Kimchi-Sarfaty, 2007, Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene, Pharmacogenomics, 8, 29, 10.2217/14622416.8.1.29

Kutanzi, 2011, MicroRNA-mediated drug resistance in breast cancer, Clin. Epigenetics, 2, 171, 10.1007/s13148-011-0040-8

Kwan, 2005, Potential role of drug transporters in the pathogenesis of medically intractable epilepsy, Epilepsia, 46, 224, 10.1111/j.0013-9580.2005.31904.x

Ling, 1997, Multidrug resistance: molecular mechanisms and clinical relevance, Cancer Chemother. Pharmacol., 40, S3, 10.1007/s002800051053

Longo, 2010, Pharmacogenetics in breast cancer: focus on hormone therapy, taxanes, trastuzumab and bevacizumab, Expert Opin. Investig. Drugs, 19, S41, 10.1517/13543781003732701

Luqmani, 2005, Mechanisms of drug resistance in cancer chemotherapy, Med. Princ. Pract., 14, 35, 10.1159/000086183

Mizuno, 2002, Drug transporters: their role and importance in the selection and development of new drugs, Drug Metab. Pharmacokinet., 17, 93, 10.2133/dmpk.17.93

Ozawa, 2004, Ethnic differences in genetic polymorphisms of CYP2D6, CYP2C19, CYP3As and MDR1/ABCB1, Drug Metab. Pharmacokinet., 19, 83, 10.2133/dmpk.19.83

Pfaffl, 2002, Relative expression software tool (REST (c)) for group-wise comparison and statistical analysis of relative expression results in real-time PCR, Nucleic Acids Res., 30, 10.1093/nar/30.9.e36

Podo, 2010, Triple-negative breast cancer: present challenges and new perspectives, Mol. Oncol., 4, 209, 10.1016/j.molonc.2010.04.006

Pogoda, 2013, Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients, Med. Oncol., 30, 10.1007/s12032-012-0388-4

Rastogi, 2008, Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27, J. Clin. Oncol., 26, 778, 10.1200/JCO.2007.15.0235

Rizzo, 2010, Association of CYP1B1 with hypersensitivity induced by Taxane therapy in breast cancer patients, Breast Cancer Res. Treat., 124, 593, 10.1007/s10549-010-1034-5

Rodrigues, 2008, Correlation of polymorphism C3435T of the MDR-1 gene and the response of primary chemotherapy in women with locally advanced breast cancer, Genet. Mol. Res., 7, 177, 10.4238/vol7-1gmr400

Sabatier, 2011, A gene expression signature identifies two prognostic subgroups of basal breast cancer, Breast Cancer Res. Treat., 126, 407, 10.1007/s10549-010-0897-9

Sauna, 2007, Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer, Cancer Res., 67, 9609, 10.1158/0008-5472.CAN-07-2377

Schinkel, 2003, Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview, Adv. Drug Deliv. Rev., 55, 3, 10.1016/S0169-409X(02)00169-2

Sensorn, 2013, Association of CYP3A4/5, ABCB1 and ABCC2 polymorphisms and clinical outcomes of Thai breast cancer patients treated with tamoxifen, Curr. Pharmacogenomics Pers. Med., 6, 93, 10.2147/PGPM.S44006

Sharom, 2008, ABC multidrug transporters: structure, function and role in chemoresistance, Pharmacogenomics, 9, 105, 10.2217/14622416.9.1.105

Tazzite, 2016, Association between ABCB1 C3435T polymorphism and breast cancer risk: a Moroccan case-control study and meta-analysis, BMC Genet., 17, 126, 10.1186/s12863-016-0434-x

Tran, 2006, Pharmacokinetics and toxicity of docetaxel: role of CYP3A, MDR1, and GST polymorphisms, Clin. Pharmacol. Ther., 79, 570, 10.1016/j.clpt.2006.02.003

Tulsyan, 2014, Assessment of clinical outcomes in breast cancer patients treated with taxanes: multi-analytical approach, Gene, 543, 69, 10.1016/j.gene.2014.04.004

Tulsyan, 2016, The effect of ABCB1 polymorphisms on the outcome of breast cancer treatment, Curr. Pharmacogenomics Pers. Med., 9, 47

Vaclavikova, 2009, The role of ABCB1 transporter gene in breast cancer resistance, Cancer Res., 69, 297s

Wei, 2011, Polymorphisms of ERCC1 C118T/C8092A and MDR1 C3435T predict outcome of platinum-based chemotherapies in advanced non-small cell lung cancer: a meta-analysis, Arch. Med. Res., 42, 412, 10.1016/j.arcmed.2011.07.008

Wu, 2012, Roles of ABCB1 gene polymorphisms and haplotype in susceptibility to breast carcinoma risk and clinical outcomes, J. Cancer Res. Clin. Oncol., 138, 1449, 10.1007/s00432-012-1209-z

Zhang, 2011, Polymorphisms of GSTP1 is associated with differences of chemotherapy response and toxicity in breast cancer, Chin. Med. J., 124, 199

Zhou, 2008, Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition, Xenobiotica, 38, 802, 10.1080/00498250701867889

Thông tin
Thông tin xuất bản

Meta Gene

Tập 16

21-27

Thông tin tác giả